Trial intelligence / Profile preview

Clopidogrel for Early AV Fistula Failure

NCT03289520Phase 3Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Jan 2003
Primary completion
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clopidogrel in arteriovenous fistula thrombosis (AVFT), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2003; status: completed.

02

Drugs

clopidogrel
03

Conditions

arteriovenous fistula thrombosis (AVFT)

Beyond the preview

Go deeper on NCT03289520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03289520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call